Exciting advancements in kidney health are on the horizon, with new drugs like SGLT2 inhibitors offering hope where there was once only supportive care. The recent passage of legislation for lifelong Medicare coverage of immunosuppressants for transplant recipients marks a significant step forward. A push for increased interest in nephrology aims to attract fresh talent and innovative ideas to improve treatment options for patients.
